Imatinib
106261-49-8
White or off-white powder
Water content ≤ 0.5%
Loss on drying ≤ 0.5%
Purity > 99.2%, total impurities ≤ 0.8%
Content 98.0-102.0%
Availability: | |
---|---|
Product Description
We are a pharmaceutical intermediate manufacturer of 106261-49-8 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride.
Its CAS No. is 106261-49-8
Our pharmaceutical intermediates can be used in a variety of APIs such as Articaine, Pyrantel, Bicalutamide, etc.
Product Category | Imatinib |
CAS NO | 106261-49-8 |
Product Specifications | White or off-white powder Water content ≤ 0.5% Loss on drying ≤ 0.5% Purity > 99.2%, total impurities ≤ 0.8% Content 98.0-102.0% |
106261-49-8 4-[(4-METHYLPIPERAZIN-1-YL)METHYL]BENZOIC ACID DIHYDROCHLORIDE.pdf
Office Environment
Laboratory
Workshop/Warehouse
Certificate
106261-49-8 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride is produced by EASTFINE , and we are in charge of overseas selling . Not just trading compamy .
China,America,Brazil,England,Russia,Poland,India,Pakistan,NewZealand,Korea,Australia,Dubai,Turkey,Indonesia,UAE.
yes , you can have 1 106261-49-8 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride sample for starting the business , but it is not free
The MOQ for 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride will vary depending on the supplier and the intended use. For academic research, smaller quantities may be available. However, for industrial or pharmaceutical production, larger orders may be required. Always confirm the specific MOQ with your supplier.
This compound has several important applications, including:
Pharmaceutical Development: It is used as an intermediate in the synthesis of drug candidates, especially those targeting the central nervous system or other therapeutic areas.
Chemical Synthesis: The compound serves as a building block in the production of other bioactive molecules.
Research Applications: It is employed in biological studies to explore its effects on various receptor systems, potentially leading to the development of novel treatments.
As with any chemical compound, 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride should be handled carefully to avoid exposure. It may cause skin, eye, or respiratory irritation if not handled with proper protective measures. Researchers and laboratory workers should wear gloves, safety goggles, and lab coats when working with this substance. Ensure that work is conducted in a well-ventilated area to reduce the risk of inhalation.
This compound is typically not administered to humans or animals directly. Instead, it is used as an intermediate in chemical reactions or biological assays. Researchers may incorporate it into experimental protocols to assess its biological activity or to synthesize other compounds.
When used improperly, 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride may cause irritation to the skin, eyes, or respiratory system. It is essential to handle this compound in accordance with all safety guidelines to avoid exposure. While it is not commonly administered to humans, accidental ingestion, inhalation, or contact should be treated immediately by seeking medical attention.
This compound should be stored in a cool, dry, and well-ventilated area, away from light, heat, and moisture. It should be kept in tightly sealed containers to prevent contamination or degradation. Always follow the storage recommendations provided by the manufacturer for best results.
Yes, 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride can be used in combination with other chemicals for the purpose of drug synthesis, testing, or development. However, compatibility testing should be performed to ensure that no unwanted reactions occur when combining it with other substances.